Literature DB >> 12015478

Cardiomyopathy and heart transplantation in children.

Jeffrey A Towbin1.   

Abstract

Cardiac transplantation has become a standard therapeutic option for certain disorders in which poor cardiac output without other surgical options exists in the face of maximized medical therapy. The most common disorder requiring transplantation is dilated cardiomyopathy, although other forms of cardiomyopathy (ie, restrictive cardiomyopathy, arrhythmogenic right ventricular dysplasia/cardiomyopathy, and hypertrophic cardiomyopathy with poor ventricular function) may require transplantation as well. In this review, the current indications and outcomes of heart transplantation in patients with cardiomyopathy are discussed.

Entities:  

Mesh:

Year:  2002        PMID: 12015478     DOI: 10.1097/00001573-200205000-00011

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  5 in total

Review 1.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

Review 2.  Congestive Heart Failure in Infants and Children.

Authors:  Mukti Sharma; Mng Nair; S K Jatana; B N Shahi
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy.

Authors:  Biagio A Pietra; Paul F Kantor; Heather L Bartlett; Clifford Chin; Charles E Canter; Ranae L Larsen; R Erik Edens; Steven D Colan; Jeffrey A Towbin; Steven E Lipshultz; James K Kirklin; David C Naftel; Daphne T Hsu
Journal:  Circulation       Date:  2012-07-16       Impact factor: 29.690

4.  Idiopathic restrictive cardiomyopathy in children.

Authors:  L M Russo; S A Webber
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

5.  Association between ACR1 gene product expression and cardiomyopathy in children.

Authors:  Yan Wang; Ling Niu; Xiuhua He; Ying Xue; Nan Ling; Zhenzhou Wang; Xinjiang An
Journal:  Exp Ther Med       Date:  2016-07-05       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.